Related Experiment Video

Updated: Jun 6, 2025

Controlling Parkinson's Disease With Adaptive Deep Brain Stimulation
11:12

Controlling Parkinson's Disease With Adaptive Deep Brain Stimulation

Published on: July 16, 2014

22.4K

Chinese guidelines on remote programming of deep brain stimulation for patients with Parkinson's disease

Fangang Meng1,2, Jie Zhang3, Wenbin Zhang4

  • 1Department of Functional Neurosurgery, Beijing Neurosurgical Institute, Beijing Tiantan Hospital, Capital Medical University, Beijing 100070, China.

Chinese Medical Journal
|November 27, 2024
PubMed
Abstract

No abstract available in PubMed .

More Related Videos

Author Spotlight: Automated Deep Brain Stimulation for Parkinson's Disease - Exploring the Possibilities and Challenges of Home Monitoring
06:32

Author Spotlight: Automated Deep Brain Stimulation for Parkinson's Disease - Exploring the Possibilities and Challenges of Home Monitoring

Published on: July 14, 2023

1.2K
Targeting Neuronal Fiber Tracts for Deep Brain Stimulation Therapy Using Interactive, Patient-Specific Models
14:14

Targeting Neuronal Fiber Tracts for Deep Brain Stimulation Therapy Using Interactive, Patient-Specific Models

Published on: August 12, 2018

8.8K

Related Experiment Videos

Last Updated: Jun 6, 2025

Controlling Parkinson's Disease With Adaptive Deep Brain Stimulation
11:12

Controlling Parkinson's Disease With Adaptive Deep Brain Stimulation

Published on: July 16, 2014

22.4K
Author Spotlight: Automated Deep Brain Stimulation for Parkinson's Disease - Exploring the Possibilities and Challenges of Home Monitoring
06:32

Author Spotlight: Automated Deep Brain Stimulation for Parkinson's Disease - Exploring the Possibilities and Challenges of Home Monitoring

Published on: July 14, 2023

1.2K
Targeting Neuronal Fiber Tracts for Deep Brain Stimulation Therapy Using Interactive, Patient-Specific Models
14:14

Targeting Neuronal Fiber Tracts for Deep Brain Stimulation Therapy Using Interactive, Patient-Specific Models

Published on: August 12, 2018

8.8K

Related Concept Videos

Parkinson's Disease: Treatment01:24

Parkinson's Disease: Treatment

220
Neurodegenerative disorders, such as Parkinson's Disease (PD), involve the gradual and irreversible destruction of neurons in particular brain areas. These disorders exhibit standard features like proteinopathies, selective vulnerability of some neurons, and an interaction of intrinsic properties, genetics, and environmental influences in neural injury.
Parkinson's Disease is primarily a result of the loss of dopaminergic neurons in the substantia nigra pars compacta. The cornerstone of...
220

Articles linked to this work by shared authors, journal, and citation graph.

An On-Demand Functionalizable Neural Electrode Interface for Precise Interrogation and Biofunctional Regulation.

ACS applied materials & interfaces·2026

Integrated Multi-Omics Analysis and Experimental Validation Identify Acetylation-Related Genes as Potential Regulators in Osteoarthritis.

Biomedicines·2026

TAB2 Causes Neuronal Damage by Aggravating Microglia-Mediated Neuroinflammation in Parkinson's Disease.

Advanced science (Weinheim, Baden-Wurttemberg, Germany)·2026

Percent Tolerance to Phosphorus Deficiency (PTPD) as a Potential Metric for Genotypic Screening in Soybean (Glycine max L.).

Plants (Basel, Switzerland)·2026

Direct Substantia Nigra Deep Brain Stimulation in Parkinson's Disease: Efficacy, Safety, and the Frequency-Response Relationship.

Brain stimulation·2026

Gait-cycle-locked cortico-subthalamic signatures underlying freezing of gait and their modulation in Parkinson's disease.

Neurobiology of disease·2026

Single-cell RNA sequencing uncovers m6A regulator-defined T-cell subpopulations and YTHDF1-HSP90AB1-MYC therapeutic axis in T-cell acute lymphoblastic leukemia.

Chinese medical journal·2026

Novel targeted therapy and cellular immunotherapy enabling allogeneic hematopoietic stem cell transplantation for relapsed/refractory acute myeloid leukemia.

Chinese medical journal·2026

Biomaterials for metabolic reprogramming in skeletal disorders.

Chinese medical journal·2026

Integrating environmental and behavioral tracking via digital health systems for personalized skin health management.

Chinese medical journal·2026

Association of dietary lecithin intake with mild cognitive impairment and cognitive performance in elderly population.

Chinese medical journal·2026

Lactylation modification of tumor suppressor proteins promotes immune tolerance in hepatocellular carcinoma.

Chinese medical journal·2026

Blood-brain barrier penetration and tissue distribution of the selective membrane progesterone receptor α (mPRα/PAQR7) agonist Org OD 02-0.

Frontiers in endocrinology·2026

Pharmacokinetic and Pharmacodynamic Bio-Similarity of ADL-018 to Innovator Omalizumab: A Randomized Study in Healthy Adults.

Clinical pharmacology in drug development·2026

The neurosteroid paradigm in perinatal depression: From pathophysiology to precision therapeutics.

Journal of neuroendocrinology·2026

In Vivo Real-Time Detection of Phenylephrine in Mice Using Boron-Doped Diamond Microelectrodes with Simultaneous Video-Based Assessment of Pupil Size.

ACS sensors·2026

Semaglutide Bioavailability: Limitations, Formulation Innovation and Future Opportunities.

Pharmaceutical research·2026

Considerations for the dynamic role of bile acids during oral drug discovery and development.

npj drug discovery·2026
See all related articles
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies
Jove
Visualize
Contact Us